ADAM17 Antikörper (C-Term)
-
- Target Alle ADAM17 Antikörper anzeigen
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADAM17 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Spezifität
- 80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
- Aufreinigung
- Affinity chromatography purified via peptide column
- Top Product
- Discover our top product ADAM17 Primärantikörper
-
-
- Applikationshinweise
- TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
-
ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
: "
-
ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
-
- Target
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
- Andere Bezeichnung
- TACE (ADAM17 Produkte)
- Molekulargewicht
- Predicted: 93 kDa
- Pathways
- Notch Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Response to Growth Hormone Stimulus
-